Veradigm Income from Discontinued Operations 2010-2022 | MDRX
Veradigm income from discontinued operations from 2010 to 2022. Income from discontinued operations can be defined as income or loss from the complete discontinuation of a segment or business, net of associated taxes and fees.
| Veradigm Annual Income from Discontinued Operations (Millions of US $) |
|
|---|---|
| 2022 | $-66 |
| 2021 | $12 |
| 2020 | $724 |
| 2019 | $56 |
| 2018 | $451 |
| 2017 | $30 |
| 2016 | $-28 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
| 2010 | $0 |
| 2010 | $0 |
| 2009 | $0 |
| Veradigm Quarterly Income from Discontinued Operations (Millions of US $) |
|
|---|---|
| 2022-12-31 | $-7 |
| 2022-09-30 | $4 |
| 2022-06-30 | $-67 |
| 2022-03-31 | $4 |
| 2021-12-31 | $15 |
| 2021-09-30 | $-4 |
| 2021-06-30 | $-4 |
| 2021-03-31 | $5 |
| 2020-12-31 | $683 |
| 2020-09-30 | $14 |
| 2020-06-30 | $14 |
| 2020-03-31 | $12 |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | $476 |
| 2018-09-30 | $-12 |
| 2018-06-30 | $-10 |
| 2018-03-31 | $-3 |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | |
| 2011-09-30 | |
| 2011-06-30 | |
| 2011-03-31 | |
| 2010-12-31 | |
| 2010-09-30 | |
| 2010-06-30 | |
| 2010-05-31 | |
| 2010-03-31 | |
| 2010-02-28 | |
| 2009-12-31 | |
| 2009-11-30 | |
| 2009-09-30 | |
| 2009-08-31 | |
| 2009-05-31 | |
| 2009-02-28 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.509B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.059B | 59.87 |
| Doximity (DOCS) | United States | $11.521B | 53.34 |
| Hims & Hers Health (HIMS) | United States | $11.158B | 115.93 |
| Tempus AI (TEM) | United States | $11.000B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.915B | 0.00 |
| Hinge Health (HNGE) | United States | $4.037B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.827B | 59.80 |
| Privia Health (PRVA) | United States | $2.804B | 191.67 |
| Enovis (ENOV) | United States | $1.791B | 9.99 |
| Phreesia (PHR) | United States | $1.693B | 0.00 |
| Schrodinger (SDGR) | United States | $1.476B | 0.00 |
| 10x Genomics (TXG) | United States | $1.426B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.420B | 0.00 |
| Azenta (AZTA) | United States | $1.409B | 65.49 |
| Omnicell (OMCL) | United States | $1.377B | 24.30 |
| Evolent Health (EVH) | United States | $1.322B | 112.60 |
| Claritev (CTEV) | United States | $0.742B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.605B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.495B | 0.00 |
| Talkspace (TALK) | United States | $0.465B | 139.00 |
| Standard BioTools (LAB) | United States | $0.456B | 0.00 |
| TruBridge (TBRG) | United States | $0.352B | 780.67 |
| Outset Medical (OM) | United States | $0.340B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.262B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.255B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.207B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.165B | 0.00 |
| American Well (AMWL) | United States | $0.139B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.133B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.105B | 0.00 |
| Pulmonx (LUNG) | United States | $0.104B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.81 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.086B | 0.00 |
| 111 (YI) | China | $0.062B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.049B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.031B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |